![Brigit Riley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Brigit Riley worked as Vice President at Sangamo Therapeutics, Inc. from 2014 to 2019 and as Chief Scientific Officer at Adverum Biotechnologies, Inc. from 2021 to 2024.
She completed her undergraduate degree at Northwestern University and her doctorate at the University of Minnesota.
Former positions of Brigit Riley
| Companies | Position | End |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 29/01/2024 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 |
Training of Brigit Riley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
- Stock Market
- Insiders
- Brigit Riley
